EUROPEAN GLAUCOMA RESEARCH TRAINING PROGRAM FOR ACCELERATING THE APPROACH TO ADVANCED GLAUCOMA
Glaucoma is the most common age-related neurodegenerative eye disease in Western society and one of the four major eye diseases causing blindness. Unfortunately, current treatments can only slow the deterioration but do not halt or reverse the process. Despite the efforts of the early detection and treatment of the disease, currently, approximately 15% of all glaucoma patients in the EU still become bilaterally blind.
Our European MARIE SKŁODOWSKA-CURIE Doctoral Network (DN) EGRET-AAA (‘European Glaucoma REsearch Training program for Accelerating the Approach to Advanced Glaucoma‘) will focus specifically on finding solutions for those patients suffering from advanced glaucoma. We aim to bring revolutionary therapies for protecting and restoring vision in patients with advanced glaucoma a significant step closer to clinical deployment.
LATEST NEWS
Seeing the light! Our 4th EGRET-AAA workshop in Trondheim
Now that all 15 DCs have started their PhD journey, we are excited to share our activities in the 4th EGRET-AAA workshop which took place on 10 - 13 March 2025 in Trondheim, Norway! This workshop was organized by our DC Richie and the Bulbitech team. In this workshop...
The EGRET-AAA DCs have been chosen!
All 15 projects have been filled! We are very excited to announce that all projects in EGRET-AAA have been assigned to extremely motivated and talented DCs. This means that we can now start enjoying the groundbreaking work these 15 individuals will produce during the...
Six DCs presented at DOPS 2024
Six of our EGRET-AAA DCs had the pleasure to present their work for the first time at the Dutch Ophthalmology PhD Students (DOPS) conference "Expanding HorEYEzons." in Nijmegen, Netherlands on 1 - 2 November 2024. At this conference they were able to discuss their...
OUR NETWORK
OUR MISSION
We want to bring revolutionary therapies for protecting and restoring vision in patients with advanced glaucoma a significant step closer to clinical deployment.
OUR PROJECTS
Joint-doctorates can work on 15 project available in academia, at medical institutes and high-tech companies in the Netherlands, Germany, France and Norway
OUR TRAINING
We offer our joint-doctorates a 3-years multidisciplinary PhD training consisting of several secondments and high-level training courses and workshops throughout Europe
OUR CONSORTIUM
EGRET-AAA consists of 24 members amongst which world-class experts in ophthalmology, ophthalmogenetics, molecular biology, visual neuroscience, and technology